Clinical Trials Logo

Filter by:
NCT ID: NCT03448406 Completed - Heart Failure Clinical Trials

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.

Start date: March 20, 2018
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus placebo on exercise ability using the 6 minute walk test (6MWT) in patients with chronic heart failure (CHF) with preserved ejection fraction (LVEF > 40%). Secondary objectives are to assess Patient-Reported Outcome (PRO)

NCT ID: NCT03447990 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction

v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491

Start date: February 6, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this Phase 1b/2a study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MYK-491 in patients with stable heart failure.

NCT ID: NCT03446560 Completed - Clinical trials for Sleep Apnea Syndromes

Cloud Based Follow up of CPAP Treatment

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Obstructive sleep apnea (OSA) is treated with a continuous positive airway pressure, so called CPAP. A new technology that enables telemetric monitoring of CPAP therapy. This study randomizes 560 patients to A) conventional follow up procedures or B to a telemedicine based follow up procedure. Main endpoint parameter is CPAP treatment compliance at 3 months after start of treatment.

NCT ID: NCT03444545 Completed - Cardiac Output, Low Clinical Trials

Continous Cardiac Output - Non-Invasive Evaluation (CONNIE)

CONNIE
Start date: October 29, 2015
Phase:
Study type: Observational

The capnodynamic method non-invasively calculates effective pulmonary blood flow (EPBF) continuously during surgery. In this study EPBF is compared to cardiac output (CO) measured with Transpulmonary Thermodilution (TPTD) att baseline and during hemodynamic changes in patients scheduled for open abdominal surgery at the Karolinska University Hospital, Solna, Sweden.

NCT ID: NCT03443011 Completed - Diverticulitis Clinical Trials

Diagnostics in Diverticulitis (DIDit)

Start date: January 19, 2017
Phase: N/A
Study type: Interventional

This study focuses on if low dose CT without intravenous contrast has a high enough specificity and sensitivity for acute diverticulitis that it can be used as the primary diagnostic method instead of a full dose CT with intravenous contrast which is the standard method in Sweden.

NCT ID: NCT03442257 Completed - Hypertension Clinical Trials

Text Message Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension

PUSH-ME
Start date: March 19, 2018
Phase: N/A
Study type: Interventional

The primary objective of the study is to examine the impact of lifestyle advices, administered through regularly sent SMS, on hypertension in a primary health care setting. The secondary objective is to evaluate changes in other cardiovascular risk factors and general health, e.g. tobacco use, obesity, blood lipids, blood glucose, self-rated health and health-related quality of life.

NCT ID: NCT03441490 Completed - Anxiety Clinical Trials

Internet-delivered Cognitive Behavioural Therapy for Adolescents With Anxiety

Start date: February 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of learning support and chat on treatment outcome in internet-administrated cognitive behaviour therapy (ICBT) for adolescents with anxiety.

NCT ID: NCT03441412 Completed - Healthy Volunteers Clinical Trials

A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor

Start date: February 28, 2018
Phase: Phase 1
Study type: Interventional

The study is an experimental observational study in ten healthy volunteers. Based on an in vitro study, it is hypothesize that a low dose epinephrine infusion will improve platelet function in healthy volunteers who have received ticagrelor. Volunteers fulfilling all of the inclusion and none of the exclusion criteria will be included. Enrollment will be continued until the required sample size is achieved (10 subjects). Once informed consent is obtained, screening data will be collected to determine each subject's eligibility for study participation. The total expected duration of subject participation is 18 days, from screening visit to end of follow-up. The active participation is 8h (study procedure 4 hours, observation period 4 hours).

NCT ID: NCT03441204 Completed - Clinical trials for Chronic Respiratory Failure With Hypoxia

REgistry-based Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX)

REDOX
Start date: May 16, 2018
Phase: Phase 4
Study type: Interventional

Multicenter, phase IV, non-superiority, registry-based, randomized controlled trial. Patients starting long-term oxygen therapy (LTOT) are randomized between LTOT prescribed 24 h/day or 15 h/day using the Swedish Register for Respiratory Failure (Swedevox). Clinical follow-up and concurrent treatments are according to routine clinical practice. The main endpoints of mortality, hospitalizations, and incident disease are assessed using Swedish registry data, with expected complete follow-up. Patient-reported outcomes are assessed using a posted questionnaire at 3 and 12 months. The study is managed by the Uppsala Clinical Research Centre (UCR).

NCT ID: NCT03440385 Completed - Crohn Disease Clinical Trials

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Start date: March 7, 2018
Phase: Phase 3
Study type: Interventional

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.